Any feedback?
Literature summary for 3.4.21.37 extracted from
- A pilot randomized study of the neutrophil elastase inhibitor, Sivelestat, in patients undergoing cardiac surgery (2009), Interact. Cardiovasc. Thorac. Surg., 9, 236-240.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | It is feasible to administer neutrophil elastase inhibitor Sivelestat as a preventive measure against lung dysfunction after cardiopulmonary bypass | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| sivelestat | a specific inhibitor of neutrophil elastase, it reduces the risk for ling dysfunction in patients after undergoing on-pump coronary artery bypass surgery, clinical study, overview | Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| lung | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| neutrophil elastase | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
